stockrowIndivior Pharmaceuticals Inc.
SUPN Healthcare Drug Manufacturers Specialty & Generic
Indivior Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 4.29% from fiscal 2024.
- Revenue
- +13.4%
- EPS
- +241.5%
- Free cash flow
- +240.7%
- Total debt
- +51.6%
Quarter to September 2026, against a year earlier
Follow SUPN
Alert me
Indivior Pharmaceuticals Inc. (SUPN) Book value per share
Indivior Pharmaceuticals Inc.'s book value per share at the end of fiscal 2025 was −0.8×, compared with −2.6× in fiscal 2024. At the end of the quarter to 30 September 2026 it was −0.5×. Over the past ten years it has ranged from −2.6× (fiscal 2024) to 1.4× (fiscal 2019); the current reading is higher than 55% of that period. Indivior Pharmaceuticals Inc. ranks 76th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | −0.8× | — |
| FY2024 | −2.6× | — |
| FY2023 | −1.4× | — |
| FY2022 | 0.4× | (73.67%) |
| FY2021 | 1.4× | 149.14% |
| FY2020 | 0.6× | (60.91%) |
| FY2019 | 1.4× | 215.34% |
| FY2018 | 0.5× | — |
| FY2017 | −1.4× | — |
| FY2016 | −2.0× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | −0.5× | — |
| Jun 2026 | −1.7× | — |
| Mar 2026 | −1.2× | — |
| Dec 2025 | −0.8× | — |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| LNTH Lantheus Holdings, Inc. compare | 20.8× |
| ALKS Alkermes plc compare | 11.1× |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 9.1× |
| RDY Dr. Reddy's Laboratories Ltd compare | 4.9× |
| LQDA Liquidia Corporation compare | 2.2× |
| AMLX Amylyx Pharmaceuticals, Inc. compare | 2.2× |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 1.6× |
| HIMS Hims & Hers Health, Inc. compare | 1.4× |
| SUPN Indivior Pharmaceuticals Inc. | −0.5× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on SUPN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement